Trials / Completed
CompletedNCT01020162
Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain
Treatment of Ilioinguinal Entrapment Syndrome - a Randomised Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Göteborg University · Academic / Other
- Sex
- Female
- Age
- 15 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Neuralgic pain caused by entrapment of peripheral nerves is an often overlooked cause of chronic pelvic pain. The objective of the present study was to assess pain and quality of life in women with pain caused by entrapment of the ilioinguinal nerve, iatrogenic after surgery but also found without previous surgery. In a controlled prospective cross-over study 19 women were randomized either to medical treatment or to resection of the nerve. Statistically significant improvements were found after surgical resection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amitryptiline, gabapentin | For amitryptiline starting dose 20-30 mg at night, increasing until clinical effect. For gabapentin was the initial dose 300 mg tid with rapid increases up to 800 mg tid. |
| PROCEDURE | Resection of the ilioinguinal nerve | In general anaesthesia the nerve was identified and resected as central as possible |
Timeline
- Start date
- 1995-09-01
- Primary completion
- 2006-12-01
- Completion
- 2007-11-01
- First posted
- 2009-11-25
- Last updated
- 2009-11-25
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01020162. Inclusion in this directory is not an endorsement.